The dose-related weight loosing properties of liraglutide were evident in a phase II study with increasing doses [37]
At the same time, Chinese laboratories have the capacity to produce faster, on a larger scale, and at a lower cost, posing a significant threat to the pricing power of the original manufacturers
GLP-1 receptor agonists are peptide-based biological medications with complex molecular structures that are inherently unstable at elevated temperatures
Hwang GH, Ryu JM, Jeon YJ, Choi J, Han J, et al
Efficacy and Onset Clinically, Aqualyx has an established record of success
Similarly, immunogenic potential is an ever-present concern in macromolecular medicinal chemistry and dual agonists capable of simultaneously binding at more than one cellular site increase the risk of an immune response [12]